rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

FactSet Research Systems Inc.

FDS · NYSE

FinancialsExchanges & fin. dataIn trendAI

FDS stood above a rising 150-day average in 7 of the last 52 weekly readings, including each of the last 7 weeks. It is 20.0% above that average now. Exchanges & Financial Data: 25% of its 16 stocks in an uptrend (+6 points in four weeks); Financials: 46% (−11 points in four weeks).

Statistics

Rotation
In trend
Weeks in an uptrend
7 in a row
Industry in uptrend
25% +6 in 4 wk
Insider buys, 12 months
$126K
Insider sales, 12 months
$3.0M
Officials’ trades on record
34

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 7 of 52 weeks.

17 Apr – 16 Oct
2%31%61%Apr 26Jun 26Jul 26Sep 26Oct 26

Exchanges & fin. data: A minority of its stocks are in an uptrend and the share has been climbing. Financials: About half its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$6.9M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

34 disclosed lines: House 25, Senate 8, executive 1; 12 people.

WhoDidAmountTraded
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k15 May 2026filed 8 Jun 2026
Shelley Moore Capito Senate: U.S. Senate eFDSenatorsoldspouse$1k–$15k31 Mar 2026filed 4 Apr 2026
Shelley Moore Capito Senate: U.S. Senate eFDSenatorsold part ofspouse$1k–$15k26 Mar 2026filed 4 Apr 2026
Shelley Moore Capito Senate: U.S. Senate eFDSenatorsold part ofspouse$1k–$15k25 Mar 2026filed 4 Apr 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k13 Mar 2026filed 7 Apr 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k18 Nov 2025filed 15 Dec 2025
Julie Johnson House: U.S. House ClerkTX32soldjoint$1k–$15k1 Apr 2025filed 14 May 2025
Byron Donalds House: U.S. House ClerkFL19sold$1k–$15k13 Feb 2025filed 25 Mar 2025
Byron Donalds House: U.S. House ClerkFL19soldspouse$1k–$15k13 Feb 2025filed 25 Mar 2025
Jared Moskowitz House: U.S. House ClerkFL23sold$1k–$15k5 Jul 2024filed 19 Aug 2024
Jared Moskowitz House: U.S. House ClerkFL23solddependent child$1k–$15k5 Jul 2024filed 6 Aug 2024
Jared Moskowitz House: U.S. House ClerkFL23solddependent child$1k–$15k5 Jul 2024filed 6 Aug 2024

Insiders

Buy orders, 12 months1
Sale orders, 12 months2
Buyers · sellers1 · 2
WhoDidSharesTraded
Malcolm FrankDirectorsold1,045at $295.0212 Jan 2026filed 14 Jan 2026
Malcolm FrankDirectorsold1,527at $296.1712 Jan 2026filed 14 Jan 2026
Laurie SiegelDirectorsold1,984at $296.128 Jan 2026filed 12 Jan 2026
Laurie SiegelDirectorsold588at $296.678 Jan 2026filed 12 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Gregory T. Moskoff Company insiderMD, Controller and CAO · last 23 Sep 20260 · 4
Sanoke Viswanathan Company insiderChief Executive Officer · last 22 Sep 20260 · 0
Gilbert Ray Cisneros, Jr. HouseCA31 · last 15 May 20262 · 1
Joshua Warren Company insiderEVP, Chief Financial Officer · last 1 May 20260 · 0
Shelley Moore Capito SenateSenator · last 31 Mar 20262 · 4
Barak Eilam Company insiderDirector · last 15 Jan 20260 · 1
Laurie G. Hylton Company insiderDirector · last 15 Jan 20260 · 0
Laurie Siegel Company insiderDirector · last 15 Jan 20260 · 7
Lee Shavel Company insiderDirector · last 15 Jan 20260 · 0
Malcolm Frank Company insiderDirector · last 15 Jan 20260 · 4
Maria Teresa Tejada Company insiderDirector · last 15 Jan 20260 · 0
Robin Ann Abrams Company insiderDirector · last 15 Jan 20260 · 7

Same industry

MORN MorningstarIn trend+13%
NDAQ NasdaqIn trend+4%
MCO Moody'sJust started moving+5%
CME CME GroupAbove a falling average+8%
CBOE Cboe Global MarketsAbove a falling average+7%
ICE Intercontinental ExchangeAbove a falling average+7%
VRSK Verisk AnalyticsAbove a falling average+5%
SPGI S&P GlobalAbove a falling average+5%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Aug 202552.7%
Operating profit marginFY 2025 · to 31 Aug 202532.2%
Free cash flow marginFY 2025 · to 31 Aug 202526.6%
Return on capital employedFY 2025 · to 31 Aug 202519.8%
Cash conversionFY 2025 · to 31 Aug 2025122%
Debt to equityFY 2025 · to 31 Aug 20250.63×
Interest coverFY 2025 · to 31 Aug 202512.96×
Research spendFY 2025 · to 31 Aug 202513.0%
Dividend growthFY 2025 · to 31 Aug 20250.0%
Share count trendFY 2025 · to 15 Oct 2025-0.5%
Cash and equivalentsFY 2025 · to 31 Aug 2025$337.7M
Free cash flowFY 2025 · to 31 Aug 2025$617.5M

Analyst forecasts

No analyst forecasts yet.